Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
xterna has raised $526K in total funding. The most recent round was Pre-Seed. The last funding was announced in February 2025.
xterna's investors include BioInnovation Institute Venture Lab, Vehiculum Capital.
xterna is headquartered in London, United Kingdom.
Xterna is an engineering biology firm producing molecular binders that can identify certain cell types for medication delivery solutions.
xterna is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"xterna — Funding & Investors." VCBacked, February 25, 2025, https://www.vcbacked.co/company/xterna. Accessed October 1, 2026.
VCBacked. (2025). xterna — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/xterna
{{cite web |title=xterna — Funding & Investors |url=https://www.vcbacked.co/company/xterna |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated